Gelmetix
Macclesfield
About Gelmetix
Gelmetix develops multiple grades of polymer gel to provide affordable non-invasive alternatives to surgery for conditions like Chronic Lower Back pain and Osteoarthritis. Their lead product is a hydrogel for nucleus pulposus augmentation to relieve pain in patients suffering from Chronic Low Back Pain. Gelmetix is a diversified therapeutic biomaterials company incorporated in the UK. It has offices in London, Paris, and Manchester.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.7M
- Funding stage: Late Stage Venture
- Last round: Series C (May 2021)
- Website: gelmetix.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Commercial, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/gelmetix-79839 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.